Equillium (EQ) Change in Receivables (2023 - 2024)
Equillium (EQ) reported Change in Receivables of -$5.0 million for Q4 2024, down 14632.35% year-over-year from N/an in Q1 2024, and down 465.99% quarter-over-quarter from -$885000.0 in Q3 2024.
Equillium (EQ) Change in Receivables (2023 - 2024) Analysis & Trends
Equillium (EQ) has 2 years of Change in Receivables data on file, last reported at -$5.0 million in Q4 2024.
- Change in Receivables for Q4 2024 came in at -$5.0 million, down 14632.35% year-over-year; the trailing twelve-month figure through Dec 2024 was -$3.7 million (down 516.39% YoY), and the FY2024 annual result was -$3.7 million, down 516.39% from the prior year.
- Change in Receivables retreated to -$5.0 million in Q4 2024 per EQ's latest filing, from -$885000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $1.3 million in Q1 2024 and troughed at -$5.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -5.01 Mn |
| Dec 31, 2024 | -5.01 Mn |
| Sep 30, 2024 | -885,000.00 |
| Sep 30, 2024 | -885,000.00 |
| Jun 30, 2024 | 846,000.00 |
| Jun 30, 2024 | 846,000.00 |
| Mar 31, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | -34,000.00 |
| Dec 31, 2023 | -34,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Jun 30, 2023 | 319,000.00 |
| Jun 30, 2023 | 319,000.00 |
| Mar 31, 2023 | 586,000.00 |
| Mar 31, 2023 | 586,000.00 |